OPRX.NASDAQOptimizerx CORP

Form 4: OptimizeRx Director Cathy Klema Acquires Shares

Sentiment:

Statement of Changes in Beneficial Ownership


OptimizeRx Corp. reports that Director Cathy Klema acquired 34,517 shares of common stock on June 9, 2026, through a grant of restricted stock units.

Summary

  • Cathy Klema, a Director at OptimizeRx Corp., was granted 34,517 restricted stock units (RSUs) on June 9, 2026.
  • These RSUs represent a contingent right to receive shares of OptimizeRx common stock.
  • The RSUs are set to vest in full on the earlier of the first anniversary of the grant date or the company's next annual shareholder meeting.
  • Following this transaction, Cathy Klema beneficially owns 56,137 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation and incentive mechanism for a director rather than a significant strategic or financial development.

Positives

  • Director Cathy Klema's acquisition of restricted stock units indicates continued alignment with shareholder interests.
  • The grant of RSUs suggests a commitment to retaining key leadership and incentivizing performance.

Future Outlook

The restricted stock units will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's next annual meeting of shareholders.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to directors are a common practice in the technology and healthcare sectors, including companies like OptimizeRx, to align executive and director interests with those of shareholders and to incentivize long-term performance and retention.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director aligns their interests with long-term company performance, potentially benefiting shareholders if the stock price increases.
  • Employees: This type of compensation for directors is standard and does not directly impact employees, though it reflects the company's compensation philosophy.
  • Management: The grant reinforces the company's approach to executive and director compensation.

Next Steps

  • Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the company's next annual shareholder meeting.

Key Dates

DateDescription
06/09/2026Transaction Date: Grant of restricted stock units to Cathy Klema.
06/10/2026Date of filing of the Statement of Changes in Beneficial Ownership.

Keywords

OptimizeRx Corp, OPRX, Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.